57 results
8-K
EX-99.1
NUVB
Nuvation Bio Inc - Ordinary Shares
29 Feb 24
Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:48pm
of the NUV-422 program offset by a $0.2 million increase in personnel-related costs. Research and development expenses for the year ended December 31, 2023 … in taxes and a $0.1 million decrease in miscellaneous expenses offset by $0.2 million increase in legal fees, and a $0.2 million increase in occupancy
8-K
EX-99.1
NUVB
Nuvation Bio Inc - Ordinary Shares
2 Nov 23
Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
4:23pm
offset by a $0.4 million increase in personnel-related costs driven by stock-based compensation and other benefits.
For the three months ended
8-K
EX-99.1
mulpfb d7po55z
3 Aug 23
Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
4:17pm
8-K
EX-99.1
7z0hvgqc6q7xyt
4 May 23
Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update
12:00am
8-K
EX-99.1
t6eugw74x77y
3 Nov 22
Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides
4:13pm
8-K
EX-99.1
koxvb8himiqjz4h
4 Aug 22
Nuvation Bio Reports Second Quarter 2022 Financial Results and Provides Business Update
4:20pm
8-K
EX-99.1
kkyeby4rfj jwua
9 May 22
Nuvation Bio Reports First Quarter 2022 Financial Results and Provides Business Update
4:22pm
8-K
EX-99.1
hfvlz20hb5en 58
28 Feb 22
Nuvation Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
5:20pm
424B3
4oif2z 9yn4ahf9ba
10 Nov 21
Prospectus supplement
5:04pm
8-K
EX-99.1
dip51d0dxw
10 Nov 21
Nuvation Bio Reports Third Quarter 2021 Financial Results and Provides Business Update
4:12pm
424B3
wfopx
12 Aug 21
Prospectus supplement
5:21pm